Active Ingredient: PLERIXAFOR
Proprietary Name: PLERIXAFOR
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 24MG/1.2ML (20MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A211901
Product Number: 001
Approval Date: Jul 24, 2023
Applicant Holder Full Name: MSN LABORATORIES PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
